Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BY 4.0Communications Biology

USP32-mediated stabilization of MAPK12 promotes lung adenocarcinoma progression by inhibiting autophagy-ferroptosis

  1. 1Department of Thoracic Surgery, School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China
  2. 2Department of Neurology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China

Abstract

Lung adenocarcinoma (LUAD), the most common non-small cell lung cancer, often resists ferroptosis and autophagy—two tumor-suppressive, therapy-sensitive regulated cell death pathways. MAPK12 (a stress-responsive p38 MAPK kinase) boosts LUAD cell survival under oxidative stress, while USP32 (a LUAD-upregulated deubiquitinase) correlates with poor prognosis. However, the USP32–MAPK12 axis’s regulatory role in LUAD ferroptosis and autophagy remains uninvestigated. USP32/MAPK12 expression in LUAD tissues/cell lines was detected via Western blotting and immunohistochemistry. Functional assays (colony formation, Transwell migration, ferroptosis/mitophagy tests) were performed after gene overexpression/knockdown. Protein interactions and ubiquitination were analyzed by co-immunoprecipitation, with in vivo validation using xenograft models. USP32 overexpression in LUAD correlated with reduced overall survival; it stabilized MAPK12 by removing K48-linked ubiquitin chains to block proteasomal degradation. USP32/MAPK12 knockdown activated autophagy/ferroptosis (elevated LC3B/ACSL4/Fe²⁺/MDA, reduced GPX4/p62), inhibited LUAD cell proliferation/migration in vitro and tumor growth in vivo. Thus, targeting the USP32–MAPK12 axis may restore cell death sensitivity, representing a promising LUAD therapeutic strategy.

Related

  1. E2F7 promotes lung adenocarcinoma progression by affecting phosphorylation and stabilization of β-catenin
    Sisi Chen, Manxiang Li, Jian Liu +4
    Chinese Medical JournalPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  2. NEURL1-mediated K63-ubiquitination of SLC40A1 drives ferroptosis resistance in pathological scars: Therapeutic targeting via autophagy-activating microneedles.
    Mengzhu Lv, Jiamei Liu, Qi Dong +4
    Redox biologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  3. Plasma exosomal miR-25-3p alleviates acute pancreatitis-associated lung injury by inhibiting ferroptosis of type II alveolar epithelial cells via NOX4/NCOA4-mediated ferritinophagy
    Zixin Wang, Zijian Huang, Jiafu Wang +9
    Journal of translational internal medicinePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCEurope PMCPMC
  4. GINS1 suppresses ferroptosis by inhibiting the Hippo pathway in neuroblastoma.
    Heyun Gao, Yan Wang, Wen Zhang +6
    Molecular & cellular oncologyPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationEurope PMC
  5. Ginsenoside Rd alleviates atherosclerosis by inhibiting adipocyte ferroptosis in perivascular adipose tissues
    Xin Fu, Chuang Liu, Fudong Hu +3
    Journal of Ginseng ResearchPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationDOAJEurope PMCPMC
BibTeX
@article{zhang2026usp32mediated,
  title = {{USP32-mediated stabilization of MAPK12 promotes lung adenocarcinoma progression by inhibiting autophagy-ferroptosis}},
  author = {Qiang Zhang and Hongxu Sheng and Dongnan Ping and Jixiang Gao},
  journal = {Communications Biology},
  year = {2026},
  month = jul,
  doi = {10.1038/s42003-026-10429-z},
  url = {https://doi.org/10.1038/s42003-026-10429-z},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - USP32-mediated stabilization of MAPK12 promotes lung adenocarcinoma progression by inhibiting autophagy-ferroptosis
AU  - Qiang Zhang
AU  - Hongxu Sheng
AU  - Dongnan Ping
AU  - Jixiang Gao
PY  - 2026
DA  - 2026/07/19
JO  - Communications Biology
DO  - 10.1038/s42003-026-10429-z
UR  - https://doi.org/10.1038/s42003-026-10429-z
AB  - Lung adenocarcinoma (LUAD), the most common non-small cell lung cancer, often resists ferroptosis and autophagy—two tumor-suppressive, therapy-sensitive regulated cell death pathways. MAPK12 (a stress-responsive p38 MAPK kinase) boosts LUAD cell survival under oxidative stress, while USP32 (a LUAD-upregulated deubiquitinase) correlates with poor prognosis. However, the USP32–MAPK12 axis’s regulatory role in LUAD ferroptosis and autophagy remains uninvestigated. USP32/MAPK12 expression in LUAD tissues/cell lines was detected via Western blotting and immunohistochemistry. Functional assays (colony formation, Transwell migration, ferroptosis/mitophagy tests) were performed after gene overexpression/knockdown. Protein interactions and ubiquitination were analyzed by co-immunoprecipitation, with in vivo validation using xenograft models. USP32 overexpression in LUAD correlated with reduced overall survival; it stabilized MAPK12 by removing K48-linked ubiquitin chains to block proteasomal degradation. USP32/MAPK12 knockdown activated autophagy/ferroptosis (elevated LC3B/ACSL4/Fe²⁺/MDA, reduced GPX4/p62), inhibited LUAD cell proliferation/migration in vitro and tumor growth in vivo. Thus, targeting the USP32–MAPK12 axis may restore cell death sensitivity, representing a promising LUAD therapeutic strategy.
SN  - 2399-3642
ER  -